These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1120 related items for PubMed ID: 21816197

  • 61. [Seven-year follow-up in pupils immunized with hepatitis B vaccine and its revaccination].
    Li X, Wu J, Liu J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1996 May; 30(3):151-3. PubMed ID: 9208525
    [Abstract] [Full Text] [Related]

  • 62. Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.
    Gara N, Abdalla A, Rivera E, Zhao X, Werner JM, Liang TJ, Hoofnagle JH, Rehermann B, Ghany MG.
    Clin Infect Dis; 2015 Feb 15; 60(4):505-13. PubMed ID: 25389254
    [Abstract] [Full Text] [Related]

  • 63. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A, Study Group.
    Lancet; 2015 Feb 15; 366(9494):1379-84. PubMed ID: 16226616
    [Abstract] [Full Text] [Related]

  • 64. Hepatitis B virus infection in health care workers in Albania: a country still highly endemic for HBV infection.
    Kondili LA, Ulqinaku D, Hajdini M, Basho M, Chionne P, Madonna E, Taliani G, Candido A, Dentico P, Bino S, Rapicetta M.
    Infection; 2007 Apr 15; 35(2):94-7. PubMed ID: 17401713
    [Abstract] [Full Text] [Related]

  • 65. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
    Zhuang GH, Yan H, Wang XL, Wu Q, Wang LR, Gao HY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan 15; 40(1):8-12. PubMed ID: 16620590
    [Abstract] [Full Text] [Related]

  • 66. [Evaluation on the efficacy of recombinant hepatitis B vaccine booster immunization in 2789 children aged over 10 years].
    Chen YD, Liang XF, Yao J, Cui FQ, Li Q, Jiang ZG, Wang FZ, Fang CF, Chen RF, Su MF, Zheng XH.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Mar 15; 32(3):252-5. PubMed ID: 21457659
    [Abstract] [Full Text] [Related]

  • 67. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ.
    Vaccine; 2001 Jul 16; 19(28-29):3919-26. PubMed ID: 11427266
    [Abstract] [Full Text] [Related]

  • 68. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.
    Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM.
    Vaccine; 2010 Jan 08; 28(3):730-6. PubMed ID: 19892043
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
    Yuen MF, Lim WL, Cheng CC, Lam SK, Lai CL.
    Hepatology; 1999 Mar 08; 29(3):924-7. PubMed ID: 10051499
    [Abstract] [Full Text] [Related]

  • 71. [Study on the immuno-effects of recombinant hepatitis B vaccination in adults].
    Zhang FM, Zhao QX, Han JH, Zhou QH, Wang MC, Miao W, Li R.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Aug 08; 24(8):697-9. PubMed ID: 14521791
    [Abstract] [Full Text] [Related]

  • 72. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun 08; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. [Prevalence of hepatitis B virus infection in children of HBsAg positive parents].
    Barut HS, Günal Ö, Göral A, Etikan I.
    Mikrobiyol Bul; 2011 Apr 08; 45(2):359-65. PubMed ID: 21644080
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. [Investigation on HBV-M among hospital workers and observation on the efficacy of vaccination against type B hepatitis].
    Wu Z, Gan C, Wang A.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun 08; 15(3):165-6. PubMed ID: 7834694
    [Abstract] [Full Text] [Related]

  • 77. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN.
    Egypt J Immunol; 2014 Jun 08; 21(1):13-26. PubMed ID: 25204041
    [Abstract] [Full Text] [Related]

  • 78. Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program.
    Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, Lee MC.
    Chin Med J (Engl); 2007 Jul 05; 120(13):1155-8. PubMed ID: 17637244
    [Abstract] [Full Text] [Related]

  • 79. Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China.
    Shen L, Wang F, Wang F, Cui F, Zhang S, Zheng H, Zhang Y, Liang X, Bi S.
    Vaccine; 2012 Oct 19; 30(47):6623-7. PubMed ID: 22959987
    [Abstract] [Full Text] [Related]

  • 80. Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory.
    Zhuang GH, Yan H, Wang XL, Hwang LY, Wu Q, Wang LR, Gao HY.
    Vaccine; 2006 Mar 15; 24(12):2186-92. PubMed ID: 16310902
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 56.